Package 0093-2065-06

Brand: cilostazol

Generic: cilostazol
NDC Package

Package Facts

Identity

Package NDC 0093-2065-06
Digits Only 0093206506
Product NDC 0093-2065
Product ID 0093-2065_01457771-0b8c-4f1b-8513-01ad09ac97cc
Description

60 TABLET in 1 BOTTLE (0093-2065-06)

Marketing

Marketing Status
Marketed Since 2012-04-24
Brand cilostazol
Generic cilostazol
Sample Package No

Linked Drug Pages (1)

Cilostazol ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "01457771-0b8c-4f1b-8513-01ad09ac97cc", "openfda": {"nui": ["N0000175598", "N0000175086"], "unii": ["N7Z035406B"], "rxcui": ["242461", "242462"], "spl_set_id": ["a6292311-9cb2-49ff-b8bf-12e2dbd196cd"], "pharm_class_epc": ["Phosphodiesterase 3 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 3 Inhibitors [MoA]"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (0093-2065-06)", "package_ndc": "0093-2065-06", "marketing_start_date": "20120424"}], "brand_name": "Cilostazol", "product_id": "0093-2065_01457771-0b8c-4f1b-8513-01ad09ac97cc", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 3 Inhibitor [EPC]", "Phosphodiesterase 3 Inhibitors [MoA]"], "product_ndc": "0093-2065", "generic_name": "Cilostazol", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cilostazol", "active_ingredients": [{"name": "CILOSTAZOL", "strength": "50 mg/1"}], "application_number": "ANDA077027", "marketing_category": "ANDA", "marketing_start_date": "20120424", "listing_expiration_date": "20261231"}